OBJECTIVE: To examine condom-use decision making in the context of hypothetical pre-exposure prophylaxsis (PrEP) efficacy among men who have sex with men who use alcohol and other substances during sex. METHODS: Substance-using men who have sex with men were recruited in 4 US cities for a behavioral intervention trial. Three groups were defined as follows: men who indicated that to not use a condom for receptive/insertive unprotected anal intercourse (UAI) while using PrEP, PrEP would need to be: (1) "almost always or always" effective (high efficacy); (2) effective "at least half the time or more but not almost always or always" (mid-range efficacy corresponding to recent PrEP trial results); (3) effective "less than half the time" (low efficacy). The mid-range efficacy group was compared with the low-efficacy group (as the reference) and to the-high efficacy group (as the reference). RESULTS: Among 630 men who never used PrEP, 15.2% were in the mid-range efficacy group for receptive UAI and 34.1% in the mid-range efficacy group for insertive UAI. Scores on difficulty communicating about safer sex while high were significantly higher in the mid-range efficacy group compared with each of the other groups for both receptive and insertive UAI. Men who seemed to be differentiating PrEP use by anal sex role also scored higher on communication difficulties, although scoring lower on condom intentions. CONCLUSIONS: Communication about safer sex while under the influence of alcohol or other substances and condom intentions are important factors to consider for HIV prevention interventions for PrEP users.
OBJECTIVE: To examine condom-use decision making in the context of hypothetical pre-exposure prophylaxsis (PrEP) efficacy among men who have sex with men who use alcohol and other substances during sex. METHODS: Substance-using men who have sex with men were recruited in 4 US cities for a behavioral intervention trial. Three groups were defined as follows: men who indicated that to not use a condom for receptive/insertive unprotected anal intercourse (UAI) while using PrEP, PrEP would need to be: (1) "almost always or always" effective (high efficacy); (2) effective "at least half the time or more but not almost always or always" (mid-range efficacy corresponding to recent PrEP trial results); (3) effective "less than half the time" (low efficacy). The mid-range efficacy group was compared with the low-efficacy group (as the reference) and to the-high efficacy group (as the reference). RESULTS: Among 630 men who never used PrEP, 15.2% were in the mid-range efficacy group for receptive UAI and 34.1% in the mid-range efficacy group for insertive UAI. Scores on difficulty communicating about safer sex while high were significantly higher in the mid-range efficacy group compared with each of the other groups for both receptive and insertive UAI. Men who seemed to be differentiating PrEP use by anal sex role also scored higher on communication difficulties, although scoring lower on condom intentions. CONCLUSIONS: Communication about safer sex while under the influence of alcohol or other substances and condom intentions are important factors to consider for HIV prevention interventions for PrEP users.
Authors: Nicole B Carnegie; Steven M Goodreau; Albert Liu; Eric Vittinghoff; Jorge Sanchez; Javier R Lama; Susan Buchbinder Journal: J Acquir Immune Defic Syndr Date: 2015-05-01 Impact factor: 3.731
Authors: Kristen Underhill; Kathleen M Morrow; Christopher Colleran; Sarah K Calabrese; Don Operario; Peter Salovey; Kenneth H Mayer Journal: AIDS Behav Date: 2016-07
Authors: Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Bruce R Schackman; Tim Matheson; Moupali Das; Matthew R Golden; Shannon Huffaker; Louise F Haynes; Susan Tross; C Kevin Malotte; Antoine Douaihy; P Todd Korthuis; Wayne A Duffus; Sarah Henn; Robert Bolan; Susan S Philip; Jose G Castro; Pedro C Castellon; Gayle McLaughlin; Raul N Mandler; Bernard Branson; Grant N Colfax Journal: JAMA Date: 2013-10-23 Impact factor: 56.272
Authors: Susan Tross; Daniel J Feaster; Gabriel Thorens; Rui Duan; Zoilyn Gomez; Martina Pavlicova; Mei Chen Hu; Tiffany Kyle; Sarah Erickson; Anya Spector; Louise Haynes; Lisa R Metsch Journal: J Addict Med Date: 2015 Nov-Dec Impact factor: 3.702